Sanofi Genzyme

Head of Global Vaccines Manufacturing Excellence_All Genders

Posted on: 14 Sep 2023

Swiftwater, PA

Job Description

We are Sanofi. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives.

Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients.

We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people, and affordable access to our medicines in some of the world’s poorest countries.

We are looking a talent for the Head of Global Vaccines Manufacturing Excellence role.

About the Team:

We are Sanofi. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medicine, turning the impossible into the possible for patients. We’re transforming strategy, culture, and process through ONE Sanofi Industrial Ambition that will connect our science to the communities we serve.

Vaccines Industrial Affairs’ unique expertise in vaccine manufacturing contributes to sanofi Vaccines’ public Health mission and company growth. Our ambition is to work together as one organization to become Best in Class – the worldwide reference for vaccine manufacturing, and to maintain a sustainable and reliable supply of cost-competitive quality vaccines for our customers around the world.

Main responsibilities:

Reporting to the Head of Industrial Excellence and Strategy, the Head of Manufacturing Excellence is accountable for developing, planning and leading the performance roadmaps for MSV sites network in order to improve business performance to achieve Best in Class ambition, maintaining thus global competitiveness.

Boost industrial performance

He or she develops and lead implementation of the Sanofi Manufacturing System (SMS2.0) program for the 10 manufacturing sites in MSV regarding

Sanofi Manufacturing System to continuously improve all aspects of manufacturing operation, sustaining cost reduction improvement, in compliance with Sanofi Quality and HSE standards
Establish harmonized Production Capacity measurement system & related Asset utilization improvements
Drive Productivity improvements programs: yields & process losses, write-off,
Drive Plant cycle time and release Lead time adherence/reduction programs

He or she manages the Vaccines pipeline of procurement-related saving initiatives including

Identify and explore areas of opportunity by structuring, facilitating, and coordinating “idea generation workshops” with Procurement to find further saving initiatives on Materials, Indirect and MRO & Energy
Ensure each site has an up-to-date portfolio of savings initiatives endorsed by the Site Head

Monitor industrial performance & Compare with Benchmark to strive for best in class

He or she establishes the measurement system to monitor overall the MSV and sites performance

Organize +QDCIS dashboard from level5 and below to prepare for level 6 escalation
Monitor performance of individual sites to identify and implement improvement measures in collaboration with site senior management and site ME managers, through monthly reviews of performance versus defined targets, ensuring accountability at site level for results
Track monthly performance dashboard and monthly report
Frame budget and StratPlan exercises to focus first on performances drivers before financial impacts

Industrial Methods

Support the LTIP process through the capacity reporting in Convergence
Organize the regular update of the production capacity register
Perform Global capacity analysis for LRP and budget preparations as well as the review process.
Provide expertise services/intervention to address troubleshooting or debottlenecking of process flows related to equipment, including diagnostic for transformation

Benchmarking

Build a network internally and externally to organize benchmark studies related to the best practices in/out of our industry
Organize Team participation into the Company benchmark studies (POBOS)
Make proposals to implement the best practices in the network.

Build capabilities for industrial performance

Establish the capabilities building system for the network

Support manufacturing sites as required, ensuring that the correct organization, resources and expertise are in place. Develop and nurture Continuous Improvement champion network
Conduct and/or support Lean workshops and SMS Lean Academy training. Actively support SMS certification program.
Organize communication between sites on SMS activities to ensure best practice sharing, cross-fertilization and implementation
Leverage all Sanofi M&S Industrial Performance programs

Connect with IPL’s IPM’s community to challenge all investment projects and provide performance intervention alternatives
Promote performance mindset at all levels of the organization through Lean events, standardization and simplification initiatives, collaborators priorities setting up and review, recognition system, and learning organization.

Manage Sourcing Risk through the CMM Organization

Defining and agreeing on the procurement-related risk strategy and objectives
Regularly mapping procurement-related risk areas and identifying specific risks
Developing and implementing a Supplier Risk Framework aligned with MSV Sourcing Risk Roadmap
Owning and maintaining the risk register for materials, suppliers, specifications, regulations, and financials
Creating awareness of risk amongst procurement teams and adjacent functions to ensure effective due diligence
Prioritizing identified risks and implementing measures to prevent or minimize their impact, while ensuring alignment with the business

About you

Experience: Crisp understanding of vaccines industrial requirements and commercial universe. Economics & financial knowledge & expertise. Experience in operational roles. Demonstrated success in leading and evaluating performance improvement programs. Ability to train staff in performance improvement methodologies. Demonstrated success in establishing and maintaining cooperative partnerships at both local and international levels. Exposure to cross sites & cross GBUs networking.

Soft skills: Change management skills. Disrupts the status quo while remaining pragmatic and focus on priorities. Able to lead & animate networks, teams, experts - Strong communication skills. Strong leadership skills to engage direct team as well as manage multiple/transversal teams. Persuasion / bringing other together to gain consensus and reach global optimum. Strong capabilities on stakeholder management to drive decision making process. Complex problem solving / Judgment & decision making / Critical thinking. Result oriented. Change management skills. Business acumen

Technical skills: Strong experience in Industrial Performance or Site Manufacturing with proven track record in Lean Manufacturing Principles / Lean transformation

Drive cost efficiencies while maintaining all safety, compliance and “time to market” objectives.

Languages: Fluent in English

Sites : France (Lyon, Gentilly, Marcy l'Etoile, Val de Reuil), Swifwater, Toronto
Travel: Ability to travel worldwide ~30% of the time

#LI-FR

Pursue progress, discover extraordinary

Sanofi Genzyme

Cambridge, MA

As the specialty care global business unit of Sanofi, we are focused on rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology. More than 30 years since we began, we remain just as committed to and passionate about advancing therapies that offer hope to patients and families.

Our approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, we rapidly grew to become one of the world’s leading biotechnology companies, recognized for our pioneering development of treatments for rare genetic disorders and our innovative contributions to medical science and biomanufacturing.

Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, we also established ourselves as a leader in the field of multiple sclerosis. In 2016, our focus expanded to include Sanofi’s programs in oncology and immunology. In 2018, with the acquisitions of Bioverativ and Ablynx, we further expanded our focus to include rare blood disorders, bringing deep expertise in hematology.

Our ambition is to be the industry leader in specialty care. We currently provide more than 25 treatments to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories.
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs. These collaborations continue to guide and motivate us as we work to push the boundaries of medicine and technology to develop new and better therapies where none existed before.